chartexchange

LCTX
Lineage Cell Therapeutics, Inc.
stockNYSEAMERICAN

At CloseNov 18, 2026 3:59:59 PM EST
0.85USD+3.935%(+0.03)1,220,903
Pre-marketNov 18, 2026 9:25:30 AM EST
0.8151USD-0.086%(-0.0007)
After-hoursNov 18, 2026 4:49:30 PM EST
0.816USD-3.762%(-0.032)
Loading…
Loading…
214.48M
Healthcare
Biotechnology
HQ
Carlsbad, CA, USA
Previous Close
$0.82
Beta
1.28
52-Week High
$1.99 2026-03-02
52-Week Low
$0.77 2026-11-17
SMA 50
$0.98
SMA 200
$1.28
Avg. Vol 10D
3.15M
Avg. Vol 30D
1.98M
Avg. Vol 90D
1.44M
Relative Vol
0.62
252.95M
240.00M
24,348,055
1.3300%
1,900,000
4,298
LCTX Profile

biotime, inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what we believe to be the world's premier collection of pluripotent cell assets. the foundation of our core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products.

LCTX Performance
PeriodPriceDateChangeBeta
1W0.992026-11-12-14.38%6.250
1M0.952026-10-19-11.01%1.888
3M1.102026-08-19-22.92%1.579
6M1.202026-05-19-29.34%1.156
1Y1.712025-11-19-50.41%1.282
2Y0.902024-11-19-6.12%—
5Y2.292021-11-19-62.97%1.092
LCTX Stock Summary

Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) stock price today is $0.85, and today's volume is 1,220,903. LCTX is up 3.935% today. The 30 day average volume is 1.98M. LCTX market cap is $214.48M with 252.95M shares outstanding.